| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 133 | 142 | 143 | 143 | 156 | 170 | 176 | 178 | 186 | 194 | 219 | 212 | 229 | 228 | 248 | 250 | 261 | 270 | 279 | 279 | 271 | 195 | 251 | 279 | 302 | 326 | 495 | 360 | 367 | 410 | 421 | 428 | 446 | 463 | 489 | 475 | 502 | 534 | 564 | 563 | 594 | 619 | 648 | 634 |
| Expenses | 115 | 123 | 127 | 125 | 131 | 144 | 149 | 150 | 153 | 162 | 180 | 180 | 191 | 198 | 213 | 222 | 231 | 228 | 238 | 234 | 236 | 176 | 218 | 245 | 343 | 272 | 292 | 342 | 302 | 336 | 345 | 349 | 365 | 386 | 402 | 391 | 403 | 435 | 451 | 470 | 480 | 505 | 524 | 536 |
| EBITDA | 19 | 19 | 17 | 18 | 25 | 26 | 28 | 28 | 34 | 32 | 39 | 32 | 38 | 30 | 34 | 28 | 30 | 43 | 42 | 45 | 35 | 19 | 33 | 34 | -41 | 55 | 202 | 18 | 65 | 74 | 76 | 78 | 80 | 76 | 87 | 84 | 100 | 99 | 112 | 93 | 114 | 114 | 125 | 98 |
| Operating Profit % | 13 % | 13 % | 11 % | 12 % | 15 % | 14 % | 15 % | 15 % | 16 % | 15 % | 15 % | 13 % | 14 % | 13 % | 13 % | 11 % | 10 % | 15 % | 14 % | 15 % | 12 % | 8 % | 12 % | 10 % | -16 % | 16 % | 17 % | 4 % | 17 % | 18 % | 18 % | 18 % | 17 % | 16 % | 17 % | 17 % | 18 % | 17 % | 18 % | 16 % | 18 % | 17 % | 19 % | 15 % |
| Depreciation | 10 | 11 | 11 | 11 | 12 | 13 | 14 | 15 | 15 | 15 | 17 | 18 | 21 | 20 | 21 | 22 | 23 | 34 | 35 | 38 | 42 | 39 | 40 | 42 | 38 | 38 | 38 | 41 | 41 | 40 | 41 | 41 | 42 | 41 | 43 | 44 | 46 | 47 | 50 | 57 | 58 | 58 | 63 | 61 |
| Interest | 9 | 9 | 9 | 10 | 11 | 5 | 6 | 5 | 7 | 7 | 10 | 10 | 15 | 18 | 24 | 13 | 16 | 31 | 35 | 36 | 36 | 37 | 27 | 29 | 26 | 26 | 23 | 24 | 24 | 25 | 26 | 27 | 26 | 26 | 27 | 30 | 27 | 34 | 36 | 41 | 44 | 46 | 44 | 45 |
| Profit Before Tax | 0 | 0 | -1 | -1 | 2 | 8 | 8 | 8 | 12 | 10 | 12 | 4 | 2 | -8 | -10 | -7 | -8 | -23 | -27 | -28 | -42 | -57 | -32 | -35 | -104 | -9 | 142 | -46 | 1 | 10 | 10 | 11 | 13 | 11 | 18 | 11 | 28 | 19 | 28 | -3 | 14 | 12 | 20 | -6 |
| Tax | 0 | -0 | -1 | 1 | -2 | 3 | 3 | 3 | 4 | 4 | 2 | 2 | 2 | -1 | -3 | -1 | 3 | -2 | -2 | 1 | 9 | -11 | -5 | -1 | 9 | 4 | 43 | 4 | -1 | 8 | 5 | 7 | 8 | 7 | 7 | 8 | 5 | 5 | 7 | -11 | 7 | 6 | -1 | 2 |
| Net Profit | 0 | 1 | -1 | -2 | 4 | 5 | 5 | 5 | 8 | 6 | 10 | 1 | -0 | -6 | -8 | -6 | -11 | -21 | -25 | -29 | -50 | -46 | -27 | -35 | -114 | -13 | 99 | -50 | 2 | 3 | 5 | 4 | 6 | 4 | 11 | 3 | 24 | 14 | 21 | 8 | 7 | 6 | 21 | -8 |
| EPS in ₹ | -0.04 | -0.07 | -0.23 | -0.30 | 0.44 | 0.59 | 0.58 | 0.63 | 0.90 | 0.55 | 1.17 | 0.37 | 0.30 | -0.39 | -0.74 | -0.71 | -0.99 | -2.05 | -2.51 | -2.57 | -4.91 | -4.48 | -1.94 | -2.33 | -8.14 | -0.76 | 8.22 | -3.55 | 0.43 | 0.44 | 0.53 | 0.54 | 0.60 | 0.55 | 0.97 | 0.41 | 1.53 | 0.87 | 1.29 | 0.50 | 0.53 | 0.34 | 1.16 | -0.68 |
Healthcare Global Enterprises
Healthcare Global Enterprises
584.45
+2.15
(0.37%)
Market Cap
8,241.19 Cr
PE Ratio
321.41
Volume
77,982.00
Day High - Low
591.00 - 578.40
52W High-Low
804.65 - 472.55
Q3 Quarterly Results are out. Check out the updated financials2 days ago
View
Key Fundamentals
Market Cap
8,241.19 Cr
EPS
3.19
PE Ratio
321.41
PB Ratio
8.91
Book Value
83.98
EBITDA
422.10
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
4.93
Debt to Equity
1.78
Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
HealthCare Global Enterprises has scheduled a board meeting on February 17, 2026, to consider a fund raise proposal through rights issue of equity shares, with trading window closed from Feb 9-26.
HCG Q3FY26 Revenue Grows 13% to ₹6,331 Mn
10 days ago
10 days agoHealthcare Global Enterprises reports Q3FY26 revenue of ₹6,331 Mn, up 13% YoY, with adjusted EBITDA rising 20% to ₹1,108 Mn and margins expanding 98 bps to 17.5%.
HealthCare Global Enterprises board approved HCG ESOS 2026 covering 74,21,455 stock options with exercise price of INR 495, subject to shareholder approval.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,618.00 | #1 1,09,535.15 | 58.09 | #1 21,994.30 | 14.76 | #1 1,505 | 36.08 | 73.95 | |
1,075.85 | 1,04,655.39 | 72.27 | 7,184.10 | #1 28.65 | 1,076 | 26.01 | 61.79 | |
915.75 | 69,135.29 | 66.68 | 7,849.70 | 13.25 | 809 | -22.38 | 60.84 | |
1,836.90 | 37,539.04 | #1 44.01 | 5,575.00 | 12.29 | 790 | -34.33 | 53.23 | |
620.65 | 32,157.18 | 86.57 | 4,286.70 | 15.12 | 337 | -8.85 | 63.56 | |
1,145.10 | 30,779.19 | 59.28 | 3,771.40 | 12.59 | 481 | -33.52 | 52.88 | |
684.40 | 27,385.51 | 86.86 | 3,067.00 | 21.98 | 415 | -43.89 | 64.58 | |
453.95 | 14,366.16 | 89.67 | 1,757.00 | 27.64 | 110 | #1 54.61 | 43.50 | |
1,181.50 | 11,999.21 | 46.31 | 1,566.90 | 17.46 | 244 | 7.26 | 44.83 | |
584.45 | #10 8,241.19 | #10 321.41 | #8 2,257.70 | #5 17.03 | #10 49 | #10 -201.28 | 41.45 |
Growth Rate
Revenue Growth
17.03 %
Net Income Growth
18.16 %
Cash Flow Change
11.43 %
ROE
3.14 %
ROCE
-5.78 %
EBITDA Margin (Avg.)
4.12 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 | 3,543 |
| Fixed Assets | 529 | 568 | 685 | 828 | 970 | 1,646 | 1,382 | 1,547 | 1,553 | 1,758 | 2,442 |
| Current Assets | 122 | 201 | 244 | 220 | 273 | 304 | 435 | 502 | 580 | 680 | 844 |
| Capital Work in Progress | 42 | 155 | 148 | 174 | 153 | 46 | 30 | 22 | 18 | 83 | 25 |
| Investments | 0 | 60 | 11 | 53 | 49 | 34 | 26 | 9 | 10 | 10 | 11 |
| Other Assets | 205 | 252 | 382 | 389 | 482 | 527 | 597 | 642 | 735 | 856 | 1,065 |
| Total Liabilities | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 | 3,543 |
| Current Liabilities | 187 | 195 | 366 | 359 | 547 | 576 | 465 | 470 | 570 | 744 | 1,046 |
| Non Current Liabilities | 284 | 270 | 371 | 506 | 584 | 1,258 | 856 | 866 | 876 | 1,099 | 1,507 |
| Total Equity | 305 | 569 | 490 | 579 | 522 | 420 | 714 | 884 | 869 | 865 | 990 |
| Reserve & Surplus | 209 | 451 | 347 | 398 | 389 | 293 | 528 | 731 | 721 | 687 | 783 |
| Share Capital | 70 | 85 | 86 | 87 | 88 | 89 | 125 | 139 | 139 | 139 | 139 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 3 | 85 | -29 | -24 | -56 | -30 | 62 | 190 | -22 | -5 | -213 |
| Investing Activities | -79 | -204 | -210 | -283 | -238 | -101 | -171 | 125 | -133 | -226 | -488 |
| Operating Activities | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | 252 | 285 | 317 |
| Financing Activities | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | -64 | -42 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 70.71 % | 68.41 % | 68.40 % | 71.44 % | 71.43 % | 71.42 % | 71.39 % | 71.38 % | 71.37 % | 71.35 % | 71.30 % | 71.29 % | 71.28 % | 71.25 % | 71.23 % | 71.23 % | 71.22 % | 62.46 % | 63.78 % | 63.77 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.28 % | 0.00 % | 6.74 % | 3.95 % | 4.29 % | 2.77 % | 2.45 % | 2.16 % | 3.59 % | 3.22 % |
| DIIs | 7.82 % | 7.86 % | 6.27 % | 5.52 % | 4.90 % | 3.56 % | 4.03 % | 4.40 % | 5.54 % | 6.58 % | 7.94 % | 6.66 % | 8.52 % | 10.89 % | 11.64 % | 12.94 % | 12.47 % | 13.22 % | 18.36 % | 18.30 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 7.05 % | 9.46 % | 10.83 % | 10.07 % | 10.84 % | 11.58 % | 11.21 % | 11.60 % | 11.44 % | 10.43 % | 9.96 % | 9.68 % | 9.39 % | 9.41 % | 9.33 % | 9.60 % | 10.43 % | 10.50 % | 10.41 % | 11.20 % |
| Others | 14.42 % | 14.26 % | 14.50 % | 12.97 % | 12.83 % | 13.44 % | 13.38 % | 12.61 % | 11.65 % | 11.63 % | 4.52 % | 12.37 % | 4.07 % | 4.49 % | 3.50 % | 3.46 % | 3.43 % | 11.66 % | 3.86 % | 3.51 % |
| No of Share Holders | 13,891 | 15,065 | 20,573 | 22,362 | 23,663 | 23,018 | 24,672 | 28,707 | 28,858 | 25,931 | 27,327 | 27,289 | 27,195 | 26,529 | 29,670 | 32,820 | 45,394 | 47,028 | 46,970 | 45,366 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 399.45 | 421.10 |
| 09 Nov 2024 |  Quarterly Result Announcement | NA | 09 Nov 2024 | 423.60 | 468.10 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 531.05 | 510.60 |
| 24 May 2025 | Quarterly Result Announcement | NA | 24 May 2025 | 550.30 | 594.65 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 566.30 | 621.60 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 694.05 | 650.55 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 764.35 | 741.75 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 630.65 | 609.25 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript3 days ago
3 days agoAudio Recording Of The Investor/Analyst Meet Held On February 09 2026.7 days ago
7 days agoBoard Meeting Intimation for Considering And Approving The Proposal Of Fund Raise By Way Of Issuance Of Equity Shares Through Rights Issue8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Feb 05, 2026Adoption Of HCG Employee Stock Option Scheme 2026Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Feb 05, 2026Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.Feb 05, 2026
Feb 05, 2026Board Meeting Outcome for Outcome Of Board MeetingFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Jan 28, 2026Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of Healthcare Global Enterprises LimitedJan 23, 2026
Jan 23, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 22, 2026
Jan 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Closure of Trading WindowDec 29, 2025
Dec 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 23, 2025
Dec 23, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 22, 2025
Dec 22, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptDec 11, 2025
Dec 11, 2025Audio Recording Of The Virtual Investor & Analyst Meet Held On December 04 2025.Dec 04, 2025
Dec 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationDec 04, 2025
Dec 04, 2025Appointment Of Internal Auditor Of The Company Under Section 138 Of The Companies Act 2013.Dec 01, 2025
Dec 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 01, 2025
Dec 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 22, 2025
Nov 22, 2025Unaudited Financial Results (Standalone And Consolidated) For Quarter And Six Months Ended September 30 2025- Searchable And Legible Format.Nov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-AcquisitionNov 12, 2025
Nov 12, 2025Issuance Of Guarantee In The Form Of A Standby Letter Of Credit (SBLC) To Secure Credit Facilities Proposed To Be Availed By Cancer Care Kenya Limited Step-Down Subsidiary Of The Company In Kenya For Its Business Expansion.Nov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-AcquisitionNov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 12, 2025
Nov 12, 2025Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Six Months Ended September 30 2025.Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Approval Of Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Six Months Ended September 30 2025.Nov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Nov 11, 2025Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of Healthcare Global Enterprises Limited (The Company)Nov 05, 2025
Nov 05, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Nov 04, 2025
Nov 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 17, 2025
Oct 17, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 15, 2025
Sep 15, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Sep 13, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Sep 04, 2025Reg. 34 (1) Annual Report.Sep 03, 2025
Sep 03, 2025Notice Of 27Th Annual General Meeting And Integrated Annual Report Of The Company For FY 2024-25.Sep 03, 2025
Sep 03, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 03, 2025
Sep 03, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 40.68
ATR(14)
Volatile 23.18
STOCH(9,6)
Neutral 45.59
STOCH RSI(14)
Overbought 84.90
MACD(12,26)
Bullish 2.58
ADX(14)
Weak Trend 24.44
UO(9)
Bearish 49.06
ROC(12)
Uptrend And Accelerating 0.80
WillR(14)
Neutral -55.90
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
